Our projects aim at exploring: how the dietary or therapeutic interventions reshape the gut microbiota and affect the host physiology or disease status (e.g. obesity or cancer) ; how can we monitor and modulate human health risk factors such as antimicrobial resistance by studying the nexus where humans interact with the environmental microbial world.

​

We are interested in developing mathematical models and using computational skills for multi-omics, structural and phenotypic data to understand the intrinsic nature of the biological processes and dynamics, especially in the field of health-related microbiome and drug development.

​

Using the structural biology, big data mining and machine learning methods to develop novel drugs are also our interest.